SCHEMBL17218364

SCHEMBL17218364

CCc1cccc(/[C]=N\OCc2ccc(Cl)cc2)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ SIGMAR1 Q99720 3/20 0.37
▸ MRGPRX4 Q96LA9 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ MAOB P27338 5/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ IDO1 P14902 2/20 0.34
▸ AGXT P21549 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17218367 1.00 PPARG (0.37) PPARGPPARASIGMAR1MRGPRX4NPC1
SCHEMBL17215895 0.91 TP53 (0.35) PPARGPPARASIGMAR1NPC1RAB9A
SCHEMBL17215896 0.91 TP53 (0.35) PPARGPPARASIGMAR1NPC1RAB9A
SCHEMBL17216953 0.90 CYP3A4 (0.45) MRGPRX4MAOBMAOAMAPTIDO1
SCHEMBL17216957 0.90 CYP3A4 (0.45) MRGPRX4MAOBMAOAMAPTIDO1
SCHEMBL17216570 0.88 TP53 (0.39) PPARGPPARASIGMAR1NPC1RAB9A
SCHEMBL17216567 0.88 TP53 (0.39) PPARGPPARASIGMAR1NPC1RAB9A
SCHEMBL17218871 0.87 MAOB (0.37) NPC1RAB9AMAOBL3MBTL1MAOA
SCHEMBL17218868 0.87 MAOB (0.37) NPC1RAB9AMAOBL3MBTL1MAOA
SCHEMBL17215615 0.87 MAOB (0.39) MAOBMAOAMAPTIDO1AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 — — EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 — — US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 PPARG 3030/4885PPARA 2794/4885SIGMAR1 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback